Monopar Therapeutics (MNPR) Total assets 2016–2025
Monopar Therapeutics (MNPR) total assets at each fiscal year-end, per SEC filings.
$140.7MFY2025 · since FY2016: $2.9M → $140.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $140.7M | +133.4% |
| FY2024 | $60.3M | — |
| FY2019 | $13.4M | +82.5% |
| FY2018 | $7.3M | -26.3% |
| FY2017 | $9.9M | +243.0% |
| FY2016 | $2.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice